Small Modular Reactor Technology Experiences Renaissance Amid AI Demand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2026
0mins
Source: NASDAQ.COM
- Surging Energy Demand: AI data centers are projected to see power demand triple by 2030, with NuScale Power indicating that approximately 300 GW of new nuclear capacity will be necessary to meet this historical growth, highlighting the market potential for small modular reactor (SMR) technology.
- Nuclear Renaissance Trend: Morgan Stanley forecasts that nuclear capacity could double from 398 GW to 860 GW by 2050, with investments in the nuclear value chain potentially reaching $2.2 trillion over the next 25 years, underscoring the importance of nuclear energy in meeting future energy needs.
- Significant Technical Advantages: SMR facilities deliver reliable base load power and can be constructed in challenging or costly locations due to their smaller footprint, addressing major tech firms' needs for reducing carbon footprints, thus presenting substantial market appeal.
- Investment Risks to Consider: While NuScale and Oklo's stock prices are relatively low and they have potential to meet energy demands of AI and data centers, both companies face uncertainties regarding technology viability and market demand, necessitating cautious risk assessment by investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OKLO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OKLO
Wall Street analysts forecast OKLO stock price to rise
12 Analyst Rating
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 52.450
Low
90.00
Averages
125.11
High
175.00
Current: 52.450
Low
90.00
Averages
125.11
High
175.00
About OKLO
Oklo Inc. is an advanced nuclear technology company. The Company is engaged in developing fast fission power plants to provide clean, reliable, and affordable energy at scale. It focuses on producing electricity and heat from its Aurora powerhouses, which can run on fresh, recycled, or down-blended nuclear fuel. It is also commercializing nuclear fuel recycling technology that can convert used nuclear fuel into usable fuel for its powerhouses and those of others. Its Aurora powerhouse product line is designed with embedded safety features, to be able to run on fresh, recycled, or down-blended fuel, and to produce 15-75 megawatts of electric (MWe). Its radioisotope activities are to support domestic supply for medical, industrial, space, defense, and other critical applications. The Company's capabilities also include high-precision machining, prototyping, fabrication, inspection, procurement support, and mechanical engineering.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oklo's Isotope Test Reactor Safety Analysis Approved by DOE
- Safety Analysis Approval: The U.S. Department of Energy has approved the Documented Safety Analysis (DSA) for Oklo Isotopes' Groves Isotope Test Reactor in Texas, marking a critical milestone in the facility's safety startup process and is expected to propel the company's commercialization efforts in nuclear energy.
- Rapid Project Advancement: In less than a year, the Groves reactor has transitioned smoothly from design and construction to the final pre-startup review, demonstrating Oklo's efficient execution in advanced reactor development, which could accelerate nuclear deployment in the U.S.
- Domestic Supply Chain Development: The Groves reactor's development will strengthen the domestic supply chain for critical isotopes used in cancer diagnosis and treatment, reducing reliance on overseas suppliers and thereby mitigating supply risks and enhancing national security.
- Commercialization Blueprint: As the first advanced reactor project to receive DSA approval on privately owned land, Groves provides a viable blueprint for future commercial facilities, showcasing Oklo's innovative capabilities and market potential in the nuclear sector.
See More
Small Investments, Big Potential: Oklo and Plug Power
- Oklo Microreactor Innovation: Oklo's Aurora microreactor generates 1.5 MWe individually, but can connect to others for up to 75 MWe, making it deployable in remote areas; expected to launch in 2027, it could reshape the nuclear energy market over the next decade.
- Revenue Growth Expectations: Analysts forecast Oklo's revenue to surge from $1 million in 2026 to $55 million in 2028, driven by strong demand from cloud and AI data centers, highlighting its long-term growth potential.
- Plug Power Market Expansion: Plug Power's fuel cell systems increased from 50,000 at the end of 2021 to 74,000 by 2025, showcasing rapid growth in the hydrogen market, particularly through partnerships with major clients like Amazon and Walmart.
- Green Hydrogen Facility Development: Plug Power is building six new green hydrogen facilities for the U.S. Department of Energy and secured a 275 MW electrolyzer contract, with revenue expected to grow at an 18% CAGR from 2025 to 2028, reflecting strong demand in the green hydrogen market.
See More
Nano Nuclear Energy: Investment Opportunity in Microreactors
- Market Potential: Nano Nuclear Energy (NNE) has a market cap of $1.1 billion with a current stock price of $0.33, and despite not generating significant revenue, the potential market for its microreactor designs has attracted aggressive investors, indicating possible future growth.
- Commercialization Challenges: NNE aims for vertical integration to control the nuclear energy supply chain, including deploying microreactors and producing nuclear fuel, but must overcome significant challenges such as regulatory approval and market acceptance, which will directly impact long-term returns.
- Market Demand: The widespread adoption of microreactors requires competitive costs and rapid deployment times in remote areas like data centers, military bases, and mining sites; failure to meet these conditions could stifle NNE's growth.
- Investment Risks: While NNE's fuel fabrication and transportation businesses may succeed, the lack of strong revenue growth from microreactor sales will limit stock price surges, necessitating cautious consideration of this highly speculative opportunity.
See More
Nano Nuclear Energy Faces Major Challenges Ahead
- Commercialization Delays: Nano Nuclear Energy is currently in a pre-commercial phase and has not generated significant revenue, primarily relying on the Nuclear Regulatory Commission's licensing process; failure to advance could lead to decreased investor confidence.
- Supply Chain Control Goals: Nano aims to become a vertically integrated nuclear reactor company, controlling the entire supply chain from microreactor deployment to nuclear fuel fabrication and transportation, which could significantly enhance its market competitiveness if successful.
- Market Demand Uncertainty: While Nano's microreactors may be more cost-effective in remote areas, failure to capture these markets or delays due to construction costs exceeding estimates could severely hinder the company's growth.
- Significant Investment Risks: The future of Nano Nuclear hinges on the widespread adoption of microreactors; however, due to its high-risk nature, investors should proceed with caution as they may face returns that fall short of expectations.
See More
US Stocks Decline as Chip and AI Stocks Retreat
- Market Pressure Intensifies: The S&P 500 index fell by 0.47%, the Dow Jones Industrial Average by 0.22%, and the Nasdaq 100 by 1.09%, indicating market sensitivity to the retreat of chipmakers and AI stocks, reflecting investor concerns about future growth.
- Employment Data Impact: The June ADP employment change increased by only 98,000, below the expected 120,000, signaling signs of a slowdown in the US labor market, which exacerbated market worries about economic growth and led to stock market pressure.
- Oil Price Decline: WTI crude oil prices fell nearly 1%, hitting a 4.25-month low, as positive negotiations between US officials and Iran improved expectations for energy supply, potentially affecting future oil price trends.
- Optimistic Earnings Outlook: Bloomberg Intelligence forecasts a 23% increase in corporate earnings for Q2, close to the 30% growth in Q1, indicating that AI infrastructure stocks will drive S&P 500 earnings-per-share growth, boosting market confidence.
See More
Oklo Secures DSA Approval, Progressing Towards Reactor Criticality
- Safety Analysis Approval: Oklo announced that its Groves Isotope Test Reactor in Texas has received the Documented Safety Analysis (DSA) approval from the U.S. Department of Energy (DOE), marking the transition from documentation to final pre-startup review, with first criticality expected in July 2026.
- Clear Next Steps: Following the DSA approval, Oklo will undergo DOE's readiness review and startup approval, and once startup approval is granted, the reactor will be permitted to receive and load nuclear fuel, initiating startup testing and advancing towards commercialization.
- Isotope Business Development: The Groves facility enhances Oklo's isotope business, supporting the domestic supply chain for critical isotopes used in cancer diagnosis, space missions, and national security, which is expected to bolster the company's competitiveness in these markets.
- Market Sentiment Improvement: Despite a more than 32% decline in Oklo's stock this year, retail sentiment on Stocktwits has shifted from 'bearish' to 'neutral', with message volume significantly increasing, indicating growing market interest in the company's future prospects.
See More
Oklo's Isotope Test Reactor Safety Analysis Approved by DOE
- Safety Analysis Approval: The U.S. Department of Energy has approved the Documented Safety Analysis (DSA) for Oklo Isotopes' Groves Isotope Test Reactor in Texas, marking a critical milestone in the facility's safety startup process and is expected to propel the company's commercialization efforts in nuclear energy.
- Rapid Project Advancement: In less than a year, the Groves reactor has transitioned smoothly from design and construction to the final pre-startup review, demonstrating Oklo's efficient execution in advanced reactor development, which could accelerate nuclear deployment in the U.S.
- Domestic Supply Chain Development: The Groves reactor's development will strengthen the domestic supply chain for critical isotopes used in cancer diagnosis and treatment, reducing reliance on overseas suppliers and thereby mitigating supply risks and enhancing national security.
- Commercialization Blueprint: As the first advanced reactor project to receive DSA approval on privately owned land, Groves provides a viable blueprint for future commercial facilities, showcasing Oklo's innovative capabilities and market potential in the nuclear sector.
See More
Small Investments, Big Potential: Oklo and Plug Power
- Oklo Microreactor Innovation: Oklo's Aurora microreactor generates 1.5 MWe individually, but can connect to others for up to 75 MWe, making it deployable in remote areas; expected to launch in 2027, it could reshape the nuclear energy market over the next decade.
- Revenue Growth Expectations: Analysts forecast Oklo's revenue to surge from $1 million in 2026 to $55 million in 2028, driven by strong demand from cloud and AI data centers, highlighting its long-term growth potential.
- Plug Power Market Expansion: Plug Power's fuel cell systems increased from 50,000 at the end of 2021 to 74,000 by 2025, showcasing rapid growth in the hydrogen market, particularly through partnerships with major clients like Amazon and Walmart.
- Green Hydrogen Facility Development: Plug Power is building six new green hydrogen facilities for the U.S. Department of Energy and secured a 275 MW electrolyzer contract, with revenue expected to grow at an 18% CAGR from 2025 to 2028, reflecting strong demand in the green hydrogen market.
See More
Nano Nuclear Energy: Investment Opportunity in Microreactors
- Market Potential: Nano Nuclear Energy (NNE) has a market cap of $1.1 billion with a current stock price of $0.33, and despite not generating significant revenue, the potential market for its microreactor designs has attracted aggressive investors, indicating possible future growth.
- Commercialization Challenges: NNE aims for vertical integration to control the nuclear energy supply chain, including deploying microreactors and producing nuclear fuel, but must overcome significant challenges such as regulatory approval and market acceptance, which will directly impact long-term returns.
- Market Demand: The widespread adoption of microreactors requires competitive costs and rapid deployment times in remote areas like data centers, military bases, and mining sites; failure to meet these conditions could stifle NNE's growth.
- Investment Risks: While NNE's fuel fabrication and transportation businesses may succeed, the lack of strong revenue growth from microreactor sales will limit stock price surges, necessitating cautious consideration of this highly speculative opportunity.
See More
Nano Nuclear Energy Faces Major Challenges Ahead
- Commercialization Delays: Nano Nuclear Energy is currently in a pre-commercial phase and has not generated significant revenue, primarily relying on the Nuclear Regulatory Commission's licensing process; failure to advance could lead to decreased investor confidence.
- Supply Chain Control Goals: Nano aims to become a vertically integrated nuclear reactor company, controlling the entire supply chain from microreactor deployment to nuclear fuel fabrication and transportation, which could significantly enhance its market competitiveness if successful.
- Market Demand Uncertainty: While Nano's microreactors may be more cost-effective in remote areas, failure to capture these markets or delays due to construction costs exceeding estimates could severely hinder the company's growth.
- Significant Investment Risks: The future of Nano Nuclear hinges on the widespread adoption of microreactors; however, due to its high-risk nature, investors should proceed with caution as they may face returns that fall short of expectations.
See More
US Stocks Decline as Chip and AI Stocks Retreat
- Market Pressure Intensifies: The S&P 500 index fell by 0.47%, the Dow Jones Industrial Average by 0.22%, and the Nasdaq 100 by 1.09%, indicating market sensitivity to the retreat of chipmakers and AI stocks, reflecting investor concerns about future growth.
- Employment Data Impact: The June ADP employment change increased by only 98,000, below the expected 120,000, signaling signs of a slowdown in the US labor market, which exacerbated market worries about economic growth and led to stock market pressure.
- Oil Price Decline: WTI crude oil prices fell nearly 1%, hitting a 4.25-month low, as positive negotiations between US officials and Iran improved expectations for energy supply, potentially affecting future oil price trends.
- Optimistic Earnings Outlook: Bloomberg Intelligence forecasts a 23% increase in corporate earnings for Q2, close to the 30% growth in Q1, indicating that AI infrastructure stocks will drive S&P 500 earnings-per-share growth, boosting market confidence.
See More
Oklo Secures DSA Approval, Progressing Towards Reactor Criticality
- Safety Analysis Approval: Oklo announced that its Groves Isotope Test Reactor in Texas has received the Documented Safety Analysis (DSA) approval from the U.S. Department of Energy (DOE), marking the transition from documentation to final pre-startup review, with first criticality expected in July 2026.
- Clear Next Steps: Following the DSA approval, Oklo will undergo DOE's readiness review and startup approval, and once startup approval is granted, the reactor will be permitted to receive and load nuclear fuel, initiating startup testing and advancing towards commercialization.
- Isotope Business Development: The Groves facility enhances Oklo's isotope business, supporting the domestic supply chain for critical isotopes used in cancer diagnosis, space missions, and national security, which is expected to bolster the company's competitiveness in these markets.
- Market Sentiment Improvement: Despite a more than 32% decline in Oklo's stock this year, retail sentiment on Stocktwits has shifted from 'bearish' to 'neutral', with message volume significantly increasing, indicating growing market interest in the company's future prospects.
See More
